688319 欧林生物
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.7672.2541.9523.07917.675
总资产报酬率 ROA (%)-0.3951.2141.1361.97511.652
投入资产回报率 ROIC (%)-0.5451.6931.6022.76316.560

边际利润分析
销售毛利率 (%)93.43094.44693.55092.86593.927
营业利润率 (%)-8.0503.6190.6257.60120.852
息税前利润/营业总收入 (%)-3.9945.4884.0918.21221.991
净利润/营业总收入 (%)-8.0482.6702.3064.85422.162

收益指标分析
经营活动净收益/利润总额(%)228.24484.56733.73167.60994.906
价值变动净收益/利润总额(%)-1.0033.8366.6718.4783.512
营业外收支净额/利润总额(%)-0.0244.45480.1594.6565.231

偿债能力分析
流动比率 (X)1.6061.5251.9551.7822.561
速动比率 (X)1.4481.3811.8041.6322.343
资产负债率 (%)47.66948.34142.28239.69430.302
带息债务/全部投入资本 (%)27.29726.11518.65811.3032.665
股东权益/带息债务 (%)258.236274.486422.883757.4133,545.245
股东权益/负债合计 (%)108.733105.854134.475150.186230.013
利息保障倍数 (X)-0.9853.2274.33534.304-1,787.579

营运能力分析
应收账款周转天数 (天)575.084323.304356.438272.293194.981
存货周转天数 (天)1,337.349868.416847.387705.108733.200